Evening Session
Ulrich Laufs (Germany)
Introduction
Ulrich Laufs (Germany)
Dyslipidemia in post-ACS patients: new study results
Helen Colhoun (UK)
Current data on PCSK9i in individuals with diabetes
Klaus Parhofer (Germany)
How to use the armamentarium of novel therapeutic options in high CV risk patients with diabetes
All panellists
Clinical case discussion: clinical implications for managing dyslipidemia in high CV risk populations
Ulrich Laufs (Germany)
Conclusion and key take-away messages